Hosted on MSN1mon
Dr. Deborah Birx Confirms COVID Vaccine Was 'Not Designed to Prevent Against Infection' in Shocking RevelationDr. Deborah Birx, who served as the White House Coronavirus Response Coordinator under President Donald Trump, shared some new revelations about the COVID-19 vaccine. In an appearance on Piers ...
Hosted on MSN10mon
Dr. Deborah Birx: We need ‘transparent panel’ on COVID origins(NewsNation) — Dr. Deborah Birx, the former White House COVID-19 response coordinator, is calling for a 9/11-style commission to investigate the handling of the coronavirus pandemic, saying ...
Birx joins air-cleaning industry amid land grab for billions in federal COVID relief The former top White House coronavirus adviser under President Donald Trump, Dr. Deborah Birx, has joined an ...
Robby Soave delivers radar on Dr. Deborah Birx's recent admission about the Covid-19 vaccines. #Covid19 #Pandemic ...
Dr. Deborah Birx, who helped coordinate the U.S. COVID response and now works to boost vaccination rates, joins NewsNation to discuss the country’s first measles-related death in a decade.
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company ...
Watch the WSJ CEO Council Summit featuring White House Coronavirus Response Coordinator Dr. Deborah Birx followed by National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci.
White House coronavirus response coordinator Dr. Deborah Birx explains why masks and asymptomatic testing remain crucial to slowing the pandemic. Photo: Carlos Barria/Reuters ...
Today on Rising, Robby reacts to Dr Deborah Birx's recent admission that the Covid-19 RNA vaccine roll-out didn't fully follow the science . President Donald Trump and Elon Musk sat down with fox ...
Ambassador-at-Large, Deborah L. Birx, M.D., is the Coordinator of the United States Government Activities to Combat HIV/AIDS and U.S. Special Representative for Global Health diplomacy. Ambassador ...
Armata is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results